| Filed On | Filing |
|---|---|
| 04 Nov 2026 |
Form 4: Yarwood Jeremy, Chief Scientific Officer
Received 16,207 shares by exercise or conversion ($192K) · Gave up 7,156 shares to cover exercise price or tax ($84.6K) · Sold 9,051 shares ($115K) |
| 04 Nov 2026 |
8-K: Other Events
On March 2, 2026, Neogen Corporation (“Neogen”) announced that it had entered into a definitive agreement to sell its global Genomics business to Zoetis Inc. (“Zoetis”). This transaction is subject to customary closing conditions and reg... |
| 04 Nov 2026 | 144 |
| 03 Nov 2026 |
Form 4: Freels Joe B, Chief Commercial Officer
Received 6,345 shares as a grant or award ($75K) · Granted 31,311 Common Stock (Right to Buy) |
| 30 Oct 2026 |
Form 4: Hastings Gregory S, VP, Animal Health
Received 1,211 shares by exercise or conversion ($14.8K) · Gave up 337 shares to cover exercise price or tax ($4.11K) |
| 30 Oct 2026 |
Form 4: Woteki Catherine E, Director
Received 1,776 shares by exercise or conversion ($21.7K) |
| 30 Oct 2026 |
Form 4: Rodriguez Rafael A, Director
Received 1,776 shares by exercise or conversion ($21.7K) |
| 30 Oct 2026 |
Form 3: Burke Kevin M, Chief HR Officer
Holds 12,929 shares of Common Stock |
| 30 Oct 2026 |
Form 4: Gupta Aashima, Director
Received 1,776 shares by exercise or conversion ($21.7K) |
| 30 Oct 2026 |
Form 4: Green Ronald D, Director
Received 1,776 shares by exercise or conversion ($21.7K) |
| 30 Oct 2026 |
Form 4: Capello Jeffrey D, Director
Received 1,776 shares by exercise or conversion ($21.7K) |
| 30 Oct 2026 |
Form 4: Borel James C, Director
Received 1,776 shares by exercise or conversion ($21.7K) |
| 28 Oct 2026 | 144 |
| 26 Oct 2026 |
8-K/A: Departure/Election of Directors or Officers; Compensation
At the annual meeting of shareholders of Neogen Corporation (the “Company”) held on October 1, 2026, the Company’s shareholders approved the Neogen Corporation Amended and Restated Omnibus Incentive Plan (the “Plan”). The Plan is an amen... |
| 23 Oct 2026 |
Form 4: Hastings Gregory S, VP, Animal Health
Received 287 shares by exercise or conversion ($3.44K) · Gave up 80 shares to cover exercise price or tax ($960) |
| 23 Oct 2026 |
Form 3: Hastings Gregory S, VP, Animal Health
Holds 32,368 shares of Common Stock |
| 21 Oct 2026 |
Form 3: Walter James A, SVP of Manufacturing
Holds 28,955 shares of Common Stock |
| 21 Oct 2026 |
Form 3: Yarwood Jeremy, Chief Scientific Officer
Holds 297 shares of Common Stock |
| 21 Oct 2026 |
Form 3: Freels Joe B, Chief Commercial Officer
No securities owned |
| 20 Oct 2026 | S-8 |
Loading...